The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
post
Manufacturing Gaps in the U.S. Pharmaceutical Industry Exposed by Tariff Wars
Read More
white-paper
Assessing Animal-Derived Raw Materials for Viral Risk
Read More
post
What is Fast-Track Designation? Accelerating Life-Saving Drug Development
Read More
post
The Strategic Role of Regulatory Affairs in the Pharmaceutical Industry
Read More
Let's move from science to success.
Let’s Talk